B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Clinical trials for B-CELL NON-HODGKIN LYMPHOMA (B-NHL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON-HODGKIN LYMPHOMA (B-NHL) trials appear
Sign up with your email to follow new studies for B-CELL NON-HODGKIN LYMPHOMA (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise against tough blood cancer
Disease control OngoingThis study tests an experimental drug called odronextamab in adults with B-cell non-Hodgkin lymphoma whose cancer has returned or not responded to prior treatments. The goal is to see how well the drug shrinks tumors and to check its safety. About 515 participants will receive th…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug PIT565 tested in blood cancer patients
Disease control OngoingThis early-stage study tests a new drug called PIT565 in about 61 adults with B-cell non-Hodgkin lymphoma or B-cell acute lymphoblastic leukemia that has come back or not responded to prior treatments. The main goal is to check the drug's safety and find the best dose. This is no…
Matched conditions: B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:58 UTC